Literature DB >> 19551986

Software tool for the structural determination of glycosaminoglycans by mass spectrometry.

Bérangère Tissot1, Alessio Ceroni, Andrew K Powell, Howard R Morris, Edwin A Yates, Jeremy E Turnbull, John T Gallagher, Anne Dell, Stuart M Haslam.   

Abstract

Structural elucidation of glycosaminoglycans (GAGs) is one of the major challenges in biochemical analysis. This is mainly because of the diversity of GAG sulfation and N-acetylation patterns and variations in uronate isomers. ESI-MS and recently MALDI-MS methodologies are important strategies for investigating the molecular structure of GAGs. However, the interpretation of MS data produced by these strategies must take into account a large number of variables (including the number of monosaccharide residues, acetylations, sulfate groups, multiple charges, and exchanges between different cations). We have developed a bioinformatics tool to assist this complex interpretation task. The software is based on GlycoWorkbench, a tool for semiautomatic interpretation of glycan MS data. The tool generates the sugar backbones in all their variants (GAG family, composition, acetylation positions, and number of sulfates) and automatically matches them with the selected MS peaks. The backbones corresponding to a given peak are validated against the selected MS/MS peaks by generating all possible fragmentations. Native chondroitin sulfate and heparin oligosaccharides as well as chemically modified heparin oligomers have been successfully analyzed by MALDI- and ESI-MS and MS/MS, and the results of the semiautomated annotation of these mass spectra are presented here.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19551986     DOI: 10.1021/ac8013753

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  14 in total

Review 1.  Proteoglycomics: recent progress and future challenges.

Authors:  Mellisa Ly; Tatiana N Laremore; Robert J Linhardt
Journal:  OMICS       Date:  2010-08

Review 2.  Glycosaminoglycanomics: where we are.

Authors:  Sylvie Ricard-Blum; Frédérique Lisacek
Journal:  Glycoconj J       Date:  2016-11-30       Impact factor: 2.916

3.  Glycosaminoglycan characterization by electrospray ionization mass spectrometry including fourier transform mass spectrometry.

Authors:  Tatiana N Laremore; Franklin E Leach; Kemal Solakyildirim; I Jonathan Amster; Robert J Linhardt
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

4.  A computational framework for heparan sulfate sequencing using high-resolution tandem mass spectra.

Authors:  Han Hu; Yu Huang; Yang Mao; Xiang Yu; Yongmei Xu; Jian Liu; Chengli Zong; Geert-Jan Boons; Cheng Lin; Yu Xia; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2014-06-12       Impact factor: 5.911

5.  Generating heparan sulfate saccharide libraries for glycomics applications.

Authors:  Andrew K Powell; Yassir A Ahmed; Edwin A Yates; Jeremy E Turnbull
Journal:  Nat Protoc       Date:  2010-04-08       Impact factor: 13.491

6.  Complete mass spectral characterization of a synthetic ultralow-molecular-weight heparin using collision-induced dissociation.

Authors:  Muchena J Kailemia; Lingyun Li; Mellisa Ly; Robert J Linhardt; I Jonathan Amster
Journal:  Anal Chem       Date:  2012-06-21       Impact factor: 6.986

7.  Fluorescent-tagged heparan sulfate precursor oligosaccharides to probe the enzymatic action of heparitinase I.

Authors:  Ponnusamy Babu; Balagurunathan Kuberan
Journal:  Anal Biochem       Date:  2009-09-02       Impact factor: 3.365

8.  GAG-ID: Heparan Sulfate (HS) and Heparin Glycosaminoglycan High-Throughput Identification Software.

Authors:  Yulun Chiu; Rongrong Huang; Ron Orlando; Joshua S Sharp
Journal:  Mol Cell Proteomics       Date:  2015-04-17       Impact factor: 5.911

Review 9.  Bioinformatics and molecular modeling in glycobiology.

Authors:  Martin Frank; Siegfried Schloissnig
Journal:  Cell Mol Life Sci       Date:  2010-04-04       Impact factor: 9.261

10.  Neutralizing the anticoagulant activity of ultra-low-molecular-weight heparins using N-acetylglucosamine 6-sulfatase.

Authors:  Xianxuan Zhou; Lingyun Li; Robert J Linhardt; Jian Liu
Journal:  FEBS J       Date:  2013-03-06       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.